Skip to main content
Log in

The Role of Randomization in Bayesian and Frequentist Design of Clinical Trial

  • Published:
Topoi Aims and scope Submit manuscript

Abstract

A key role in inference is played by randomization, which has been extensively used in clinical trials designs. Randomization is primarily intended to prevent the source of bias in treatment allocation by producing comparable groups. In the frequentist framework of inference, randomization allows also for the use of probability theory to express the likelihood of chance as a source for the difference of end outcome. In the Bayesian framework, its role is more nuanced. The Bayesian analysis of clinical trials can afford a valid rationale for selective controls, pointing out a more limited role for randomization than it is generally accorded. This paper is aimed to offer a view of randomization from the perspective of both frequentist and Bayesian statistics and discussing the role of randomization also in theoretical decision models.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Altman DG, Schulz KF, Moher D, Egger M, Davidoff F, Elbourne D, Gøtzsche PC, Lang T, the CONSORT Group (2001) The revised CONSORT statement for reporting randomised trials: explanation and elaboration. Ann Intern Med 134:663–694

  • Bartlett RH, Roloff DW, Cornell RG, Andrews AF, Dillon PW, Zwischenberger JB (1985) Extracorporeal circulation in neonatal respiratory failure: a prospective randomized study. Pediatrics 76(4):479–487

    Google Scholar 

  • Berger VW (2000) Pros and cons of permutation tests in clinical trials. Stat Med 19(10):1319–1328

    Article  Google Scholar 

  • Berry SM, Kadane JB (1997) Optimal Bayesian randomization. J R Stat Soc 59(4):813–819

    Article  Google Scholar 

  • Berry SM, Bradley P, Carlin J, Lee JJ, Muller P (2010) Bayesian adaptive methods for clinical trials, Chapman & Hall, Boca Raton

    Book  Google Scholar 

  • Biswas S, Liu DD, Lee JJ, Berry DA (2009) Bayesian clinical trials at the University of Texas M. D. Anderson Cancer Center. Clin Trials 6(3):205–216

    Article  Google Scholar 

  • Brown AR, Gajewski BJ, Aaronson LS et al (2016) A Bayesian comparative effectiveness trial in action: developing a platform for multisite study adaptive randomization. Trials 17(1):428

    Article  Google Scholar 

  • Christen JA, Muller P, Wathen K, Wolf J (2004) Bayesian randomized clinical trials: a decision-theoretic sequential design. Can J Stat 32(4):387–402

    Article  Google Scholar 

  • Cox DR (2009) Randomization in the design of experiments. Int Stat Rev 77:415–429

    Article  Google Scholar 

  • Cumberland WG, Royall RM (1988) Does simple random sampling provide adequate balance? J R Stat Soc 50:118–124

    Google Scholar 

  • Efron B (1971) Forcing a sequential experiment to be balanced. Biometrika 58(3):403–417

    Article  Google Scholar 

  • Fisher RA (1935) The design of experiments. Oliver and Boyd, Edinburgh

    Google Scholar 

  • Gelman A (2008) Rejoinder. Bayesian Anal 3(3):467–478

    Article  Google Scholar 

  • Gelman A, Carlin J, Stern H, Dunson D, Vehtari A, Rubin D (2014) Bayesian data analysis, 3rd Edition, Chapman and Hall/CRC, Boca Raton

    Google Scholar 

  • Hacking I (1988) Telepathy: origins of randomization in experimental design. Isis 79:427–451

    Article  Google Scholar 

  • Hall NS (2007) RA Fisher and his advocacy of randomization. J Hist Biol 40(2):295–325

    Article  Google Scholar 

  • Hey SP, Truog RD (2015) The question of clinical equipoise and patients’ best interests. AMA J Ethics 17(12):1108–1115

    Article  Google Scholar 

  • Holland PW (1986) Statistics and causal inference. J Am Stat Assoc 81(396):945–960

    Article  Google Scholar 

  • Jiang F, Lee JJ, Muller P (2013) A Bayesian decision-theoretic sequential response-adaptive randomization design. Stat Med 32(12):1975–1994

    Article  Google Scholar 

  • Lachin JM (1988) Statistical properties of randomization in clinical trials. Control Clin Trials 9(4):289–311

    Article  Google Scholar 

  • Lee JJ, Chu CT (2012) Bayesian clinical trials in action. Stat Med 31(25):2955–2972

    Article  Google Scholar 

  • Lee JJ, Chen N, Yin G (2012) Worth adapting? Revisiting the usefulness of outcome-adaptive randomization. Clin Cancer Res 18(17):4498–4507

    Article  Google Scholar 

  • Lin Y, Zhu M, Su Z (2015) The pursuit of balance: an overview of covariate-adaptive randomization techniques in clinical trials. Contemp Clin Trials 45(Pt A):21–25

    Article  Google Scholar 

  • Little RJ (2006) Calibrated Bayes. Am Stat 60(3):213–223

    Article  Google Scholar 

  • Medical Research Council (1948) STREPTOMYCIN treatment of pulmonary tuberculosis. Br Med J 2(4582): 769–782

    Article  Google Scholar 

  • Rosenberger WF (2010) The agile approach to adaptive research. Wiley, New Jersey

    Book  Google Scholar 

  • Rosenberger WF, Lachin JM (1993) The use of response-adaptive designs in clinical trials. Control Clin Trials 14(6):471–484

    Article  Google Scholar 

  • Rosenberger WF, Lachin JM (2016) Randomization in clinical trials: theory and practice. Wiley, New York

    Book  Google Scholar 

  • Rosenberger WF, Stallard N, Ivanova A, Harper CN, Ricks ML (2001) Optimal adaptive designs for binary response trials. Biometrics 57(3):909–913

    Article  Google Scholar 

  • Rosner AL (2012) Evidence-based medicine: revisiting the pyramid of priorities. J Bodyw Mov Ther 16(1):42–49

    Article  Google Scholar 

  • Rubin DB (1978) Bayesian inference for causal effects: the role of randomization. Ann Stat 6(1):34–58

    Article  Google Scholar 

  • Rubin DB (1991) Practical implications of modes of statistical inference for causal effects and the critical role of the assignment mechanism. Biometrics 47(4):1213–1234

    Article  Google Scholar 

  • Sackett DL, Rosenberg WM, Gray JA, Haynes RB, Richardson WS (1996) Evidence based medicine: what it is and what it isn’t. BMJ 312(7023):71–72

    Article  Google Scholar 

  • Savage LJ (1962) Subjective probability and statistical practice. In: Savage LJ et al (ed) The foundations of statistical inference. Methuen, London

    Google Scholar 

  • Saxman SB (2015) Ethical considerations for outcome-adaptive trial designs: a clinical researcher’s perspective. Bioethics 29(2):59–65

    Article  Google Scholar 

  • Spiegelhalter D, Abrams K, Myles J (2004) Bayesian approaches to clinical trials and health care evaluation. Wiley, Chichester

    Google Scholar 

  • Thall PF, Wathen JK (2007) Practical Bayesian adaptive randomisation in clinical trials. Eur J Cancer 43(5):859–866

    Article  Google Scholar 

  • Urbach P (1993) The value of randomization and control in clinical trials. Stat Med 12(15–16):1421–1431. (discussion 1433–1441)

    Article  Google Scholar 

  • Wei IJ, Durham S (1978) The randomized play-the-winner rule in medical trials. J Am Stat Assoc 73:840–843

    Article  Google Scholar 

  • Worrall J (2007) Why there’s no cause to randomize. Br J Philos Sci 58(3):451–488

    Article  Google Scholar 

Download references

Acknowledgements

This research was supported by the University of Torino, Grant No. BERP_RILO_17_01.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Paola Berchialla.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Berchialla, P., Gregori, D. & Baldi, I. The Role of Randomization in Bayesian and Frequentist Design of Clinical Trial. Topoi 38, 469–475 (2019). https://doi.org/10.1007/s11245-018-9542-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11245-018-9542-8

Keywords

Navigation